{"id":"adm","safety":{"commonSideEffects":[{"rate":null,"effect":"Cardiotoxicity / cardiomyopathy"},{"rate":null,"effect":"Myelosuppression (neutropenia, anemia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Extravasation injury"}]},"_chembl":null,"_dailymed":{"setId":"10ab1c14-3e01-e12b-e063-6394a90aea2f","title":"TECHNEGAS (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M-LABELED CARBON INHALATION AEROSOL) KIT [CYCLOMEDICA AUSTRALIA PTY LIMITED]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Doxorubicin works by inserting itself between DNA base pairs (intercalation) and blocking the enzyme topoisomerase II, which normally allows DNA strands to separate during replication and transcription. This dual mechanism prevents DNA synthesis and repair, triggering apoptosis in rapidly dividing cancer cells. It is particularly effective against a broad range of malignancies including sarcomas, lymphomas, and solid tumors.","oneSentence":"ADM (doxorubicin) is an anthracycline chemotherapy agent that intercalates into DNA and inhibits topoisomerase II, leading to DNA damage and cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:26:14.680Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Soft tissue sarcoma"},{"name":"Bone sarcoma"},{"name":"Various solid tumors and hematologic malignancies"}]},"trialDetails":[{"nctId":"NCT06857929","phase":"NA","title":"\"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition\"","status":"RECRUITING","sponsor":"IMDEA Food","startDate":"2026-03-01","conditions":"Metabolic Syndrome, Obesity Prevention, Obesity and Overweight","enrollment":106},{"nctId":"NCT03907475","phase":"PHASE2","title":"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-16","conditions":"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","enrollment":115},{"nctId":"NCT04759586","phase":"PHASE3","title":"Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-05","conditions":"Primary Mediastinal Large B-Cell Lymphoma","enrollment":244},{"nctId":"NCT02306161","phase":"PHASE3","title":"Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-12","conditions":"Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Bone Marrow","enrollment":312},{"nctId":"NCT07498166","phase":"NA","title":"Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-02-01","conditions":"Achilles Tendon Rupture, Blood Flow Restriction Therapy, Achilles Tendon Repairs/Reconstructions","enrollment":75},{"nctId":"NCT07496632","phase":"NA","title":"Effect of Scalp Block on Intraoperative Hemodynamics and Postoperative Pain in Craniotomy Patients\"","status":"NOT_YET_RECRUITING","sponsor":"Bangladesh Medical University","startDate":"2026-04","conditions":"Scalp Block","enrollment":72},{"nctId":"NCT07143188","phase":"NA","title":"The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-04","conditions":"Inflammatory Bowel Disease","enrollment":42},{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia","enrollment":153},{"nctId":"NCT01087281","phase":"","title":"Top-Down Attentional Control of Visual-Processing","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2012-07-23","conditions":"Focal Brain Lesion, Focal Lesions, fMRI","enrollment":300},{"nctId":"NCT02839707","phase":"PHASE2, PHASE3","title":"Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-23","conditions":"Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma, Ovarian Seromucinous Carcinoma","enrollment":444},{"nctId":"NCT07497971","phase":"NA","title":"Utilizing Electronic Modules to Educate on Sexual Health Practices During Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"Loyola University","startDate":"2026-03","conditions":"Sexual Health Education During Pregnancy, Communication About Sexual Health in Prenatal Care, Sexual Function and Intimacy in Pregnancy","enrollment":100},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT07494318","phase":"","title":"Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.","status":"RECRUITING","sponsor":"Methodist Health System","startDate":"2018-08-02","conditions":"Gastro-Intestinal Disorder","enrollment":260},{"nctId":"NCT03914625","phase":"PHASE3","title":"A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-03","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome","enrollment":6720},{"nctId":"NCT04419740","phase":"NA","title":"Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments","status":"RECRUITING","sponsor":"University Hospital, Geneva","startDate":"2021-10-01","conditions":"Infertility, Female","enrollment":150},{"nctId":"NCT07494006","phase":"","title":"Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?","status":"ENROLLING_BY_INVITATION","sponsor":"Peking University People's Hospital","startDate":"2025-07-15","conditions":"Lung Cancer, OLV, Hypoxemia During Surgery","enrollment":44},{"nctId":"NCT07431086","phase":"PHASE2","title":"Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-16","conditions":"Overweight or Obesity","enrollment":120},{"nctId":"NCT00092222","phase":"PHASE2","title":"Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-28","conditions":"Lymphoproliferative Disorder, HHV-8, Malignancy","enrollment":75},{"nctId":"NCT07191652","phase":"","title":"The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index","status":"RECRUITING","sponsor":"Istanbul University - Cerrahpasa","startDate":"2026-03-25","conditions":"Ear Throat Nose Surgery, Delirium - Postoperative, Pain Postoperative","enrollment":120},{"nctId":"NCT07495878","phase":"NA","title":"Educational Cartoon to Reduce Preoperative Anxiety in Children (CALM-KIDS)","status":"RECRUITING","sponsor":"Mehmet Burak Eşkin","startDate":"2026-01-01","conditions":"Pediatric Preoperative Anxiety, Children, Educational Cartoon","enrollment":159},{"nctId":"NCT04216394","phase":"","title":"Anticoagulation in Emergency General Surgery","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2019-10-31","conditions":"Emergency General Surgery","enrollment":4},{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT05691478","phase":"PHASE2, PHASE3","title":"A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-03-03","conditions":"High Grade Osteosarcoma, Localized Osteosarcoma, Metastatic Osteosarcoma","enrollment":1122},{"nctId":"NCT07494071","phase":"NA","title":"Improving Family Communication in Older Adults: A Pilot Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-04","conditions":"Intergenerational Relations","enrollment":40},{"nctId":"NCT04301076","phase":"PHASE1","title":"Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-08-31","conditions":"Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma","enrollment":30},{"nctId":"NCT07498985","phase":"NA","title":"Exercise for the Treatment of Cancer-Related Sarcopenia","status":"NOT_YET_RECRUITING","sponsor":"State University of Londrina","startDate":"2026-04-01","conditions":"Cancer, Sarcopenia","enrollment":78},{"nctId":"NCT05085353","phase":"","title":"Fetal Outcomes Among Pregnant Emergency General Surgery Patients","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2020-02-25","conditions":"Pregnancy Complications, Acute Appendicitis, Acute Cholecystitis","enrollment":3},{"nctId":"NCT00980460","phase":"PHASE3","title":"Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-14","conditions":"PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma","enrollment":236},{"nctId":"NCT04225585","phase":"NA","title":"Well-Being After Breast Cancer Surgery","status":"COMPLETED","sponsor":"Duke University","startDate":"2021-06-08","conditions":"Coping Skills Training for Persistent Post-Surgical Pain, General Health Education","enrollment":316},{"nctId":"NCT04847063","phase":"PHASE1","title":"Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-19","conditions":"Peritoneal Mesothelioma, Peritoneal Carcinomatosis, Ovarian Cancer","enrollment":60},{"nctId":"NCT07498972","phase":"NA","title":"Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer","status":"COMPLETED","sponsor":"Shanxi Province Cancer Hospital","startDate":"2023-01-01","conditions":"Advanced Lung Cancer, Cancer-related Fatigue","enrollment":100},{"nctId":"NCT02865837","phase":"NA","title":"Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer","status":"COMPLETED","sponsor":"Institut de Cancérologie de Lorraine","startDate":"2015-09","conditions":"Cervical Cancer","enrollment":22},{"nctId":"NCT03383445","phase":"NA","title":"Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2017-08-08","conditions":"Degenerative Aortic Valve Disease, Aortic Stenosis, Aortic Regurgitation","enrollment":300},{"nctId":"NCT02166463","phase":"PHASE3","title":"Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-03-19","conditions":"Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma","enrollment":600},{"nctId":"NCT07495852","phase":"PHASE3","title":"Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2026-02-17","conditions":"Glaucoma","enrollment":510},{"nctId":"NCT05720884","phase":"NA","title":"Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"Ilsan Cha hospital","startDate":"2023-10-23","conditions":"Total Laparoscopic Hysterectomy","enrollment":35},{"nctId":"NCT07495787","phase":"NA","title":"Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative Metabolic Approach","status":"RECRUITING","sponsor":"iIDEAS Group Holdings Limited","startDate":"2025-04-22","conditions":"Diabete Type 2","enrollment":5},{"nctId":"NCT07494565","phase":"PHASE2","title":"Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-05","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL), CD5 Positive","enrollment":60},{"nctId":"NCT06867068","phase":"PHASE1","title":"Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2016-10-04","conditions":"Anesthesia, Tooth Extraction","enrollment":73},{"nctId":"NCT04628767","phase":"PHASE2, PHASE3","title":"Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-11-12","conditions":"Renal Pelvis and Ureter Urothelial Carcinoma","enrollment":249},{"nctId":"NCT06422806","phase":"PHASE3","title":"Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-09-11","conditions":"Metastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8","enrollment":365},{"nctId":"NCT07494292","phase":"NA","title":"Personalised Active Self-management of Sleep Apnea Program","status":"NOT_YET_RECRUITING","sponsor":"Hong Kong Metropolitan University","startDate":"2026-04-01","conditions":"Obstructive Sleep Apnea (OSA)","enrollment":60},{"nctId":"NCT02311933","phase":"PHASE2","title":"Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-05-28","conditions":"Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7","enrollment":81},{"nctId":"NCT05711615","phase":"PHASE1","title":"Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-02-06","conditions":"Metastatic Dedifferentiated Liposarcoma, Metastatic Leiomyosarcoma, Metastatic Myxofibrosarcoma","enrollment":30},{"nctId":"NCT01176006","phase":"PHASE2","title":"Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2010-10-05","conditions":"DOCK8 Deficiency","enrollment":70},{"nctId":"NCT02392429","phase":"PHASE2","title":"FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-04-20","conditions":"Acute Myeloid Leukemia","enrollment":87},{"nctId":"NCT04307576","phase":"PHASE3","title":"A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia","status":"RECRUITING","sponsor":"Mats Heyman","startDate":"2020-07-13","conditions":"Leukemia, Acute Lymphoblastic","enrollment":6430},{"nctId":"NCT00066443","phase":"PHASE1, PHASE2","title":"Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2003-11-03","conditions":"Breast Cancer","enrollment":93},{"nctId":"NCT07066306","phase":"NA","title":"Effects of Local Ketamine in Orthognathic Procedures","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bezmialem Vakif University","startDate":"2025-06-21","conditions":"Dentofacial Deformities, Analgesia, Vomiting, Postoperative","enrollment":40},{"nctId":"NCT06312176","phase":"PHASE3","title":"A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-14","conditions":"Breast Neoplasms","enrollment":1200},{"nctId":"NCT07349940","phase":"NA","title":"Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care","status":"RECRUITING","sponsor":"Institute of Health Information and Statistics of the Czech Republic","startDate":"2026-02-01","conditions":"Skin Cancer Prevention, Melanoma In Situ, Skin Lesions","enrollment":1440},{"nctId":"NCT02180867","phase":"PHASE2, PHASE3","title":"Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-07-11","conditions":"Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma","enrollment":140},{"nctId":"NCT00792948","phase":"PHASE2","title":"Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-01","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":97},{"nctId":"NCT00001244","phase":"","title":"Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1990-01-15","conditions":"XLA, CVID, Yao Syndrome","enrollment":500},{"nctId":"NCT06175715","phase":"NA","title":"General Versus Regional Anesthesia for Carotid Endarterectomy at Acute Ischemic Stroke Trial","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2024-07-01","conditions":"Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT03269669","phase":"PHASE2","title":"Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-23","conditions":"Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma","enrollment":73},{"nctId":"NCT03984448","phase":"PHASE2, PHASE3","title":"Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-22","conditions":"Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma","enrollment":363},{"nctId":"NCT07495189","phase":"","title":"A Study of the Mechanisms by Which Mood and Sleep Disorders Interact","status":"ENROLLING_BY_INVITATION","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-10-01","conditions":"Sleep Disorder Insomnia Chronic","enrollment":200},{"nctId":"NCT07391774","phase":"PHASE3","title":"Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-07","conditions":"Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8","enrollment":1978},{"nctId":"NCT06962111","phase":"NA","title":"Early-Stage Partner in Care Living Alone Plus","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-03-26","conditions":"Dementia, Mild Cognitive Impairment (MCI), Alzheimer Disease","enrollment":70},{"nctId":"NCT04530565","phase":"PHASE3","title":"Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-25","conditions":"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":348},{"nctId":"NCT05727930","phase":"NA","title":"Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-01-11","conditions":"Stroke","enrollment":100},{"nctId":"NCT00740805","phase":"PHASE1","title":"Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2008-08-18","conditions":"Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Neoplasm","enrollment":81},{"nctId":"NCT00587886","phase":"","title":"Estrogen, Diet, Genetics and Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2001-09-25","conditions":"Cancer, Endometrial Cancer, Ovarian Cancer","enrollment":1315},{"nctId":"NCT07074756","phase":"NA","title":"A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-09-12","conditions":"Glioma, Recurrent Glioma","enrollment":120},{"nctId":"NCT05675410","phase":"PHASE3","title":"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-11","conditions":"Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8","enrollment":1875},{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT00310180","phase":"PHASE3","title":"Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2006-04-07","conditions":"Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7","enrollment":10273},{"nctId":"NCT07496970","phase":"NA","title":"Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2023-03-15","conditions":"Postoperative Pain","enrollment":40},{"nctId":"NCT01856192","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-08-27","conditions":"Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma","enrollment":349},{"nctId":"NCT07497555","phase":"NA","title":"Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2025-10-15","conditions":"Overweight (BMI > 25)","enrollment":50},{"nctId":"NCT06717347","phase":"PHASE3","title":"A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-01-27","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":1046},{"nctId":"NCT07288034","phase":"PHASE2","title":"Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial","status":"NOT_YET_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-09-21","conditions":"Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8","enrollment":535},{"nctId":"NCT07444710","phase":"PHASE1","title":"Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-20","conditions":"Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma, Ann Arbor Stage IV Mantle Cell Lymphoma","enrollment":16},{"nctId":"NCT06058377","phase":"PHASE3","title":"Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-11-27","conditions":"Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma","enrollment":3680},{"nctId":"NCT01272037","phase":"PHASE3","title":"Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-02-28","conditions":"Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma","enrollment":5018},{"nctId":"NCT07251101","phase":"NA","title":"Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Ilsan Cha hospital","startDate":"2026-05-02","conditions":"Anesthesia, Intravenous, Hemodynamic Stability, Gynecologic Surgery","enrollment":58},{"nctId":"NCT07387523","phase":"NA","title":"Psychological and Lifestyle Factors That Predict Adherence of Multi-domain Interventions for Promoting Brain Health","status":"ENROLLING_BY_INVITATION","sponsor":"Institut Guttmann","startDate":"2026-02-15","conditions":"Brain Health Activities, Cognition, Prevention","enrollment":120},{"nctId":"NCT05210374","phase":"PHASE1","title":"Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-03-09","conditions":"Relapsed Sarcomas","enrollment":24},{"nctId":"NCT00004847","phase":"PHASE1","title":"Diagnosis of Pheochromocytoma","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2000-03-22","conditions":"Pheochromocytoma, Endocrine Disease, Endocrine Diseases","enrollment":3000},{"nctId":"NCT04466488","phase":"NA","title":"Prevent TB: Choice Architecture for TPT Delivery","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-09-15","conditions":"HIV/AIDS, Tuberculosis","enrollment":50798},{"nctId":"NCT07498946","phase":"NA","title":"Comparison of Paravertebral Block and Deep Parasternal Intercostal Plane Block in Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Gaziantep City Hospital","startDate":"2026-04-18","conditions":"Postoperative Pain, Cardiac Surgery, Postoperative Pain After Cardiac Surgery Via Median Sternotomy","enrollment":80},{"nctId":"NCT06280586","phase":"NA","title":"Effectiveness of Intervention in Prevention of Sarcopenia, Frailty and Functional Decline in Pre-frail Community Elderly","status":"COMPLETED","sponsor":"Consorci Sanitari del Maresme","startDate":"2021-11-15","conditions":"Muscle Strengh, Frailty, Sarcopenia","enrollment":232},{"nctId":"NCT04087798","phase":"NA","title":"Controlling Hypertension Through Education and Coaching in Kidney Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2020-02-04","conditions":"Chronic Kidney Diseases, Chronic Disease, Chronic Kidney Disease, Stage 3 (Moderate)","enrollment":320},{"nctId":"NCT07495345","phase":"NA","title":"Feasibility Study of a Novel Automated Slit Lamp Camera (Lightfield Medical Ophthalmic Camera Model Vscan001)","status":"COMPLETED","sponsor":"Lightfield Medical","startDate":"2023-07-01","conditions":"Anterior Segment of Eye","enrollment":54},{"nctId":"NCT04888923","phase":"","title":"Natural History of the Human Biological Response to Environmental Exposure and Injury","status":"RECRUITING","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2021-11-16","conditions":"Inflammation, Normal Controls, Metabolic Disease","enrollment":2000},{"nctId":"NCT07060807","phase":"PHASE3","title":"A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-21","conditions":"Breast Neoplasms","enrollment":1000},{"nctId":"NCT04092270","phase":"PHASE1","title":"A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-05-07","conditions":"Endometrial High Grade Endometrioid Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma","enrollment":54},{"nctId":"NCT07496229","phase":"PHASE1, PHASE2","title":"Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)","status":"NOT_YET_RECRUITING","sponsor":"Dizal Pharmaceuticals","startDate":"2026-03","conditions":"T-cell Lymphomas","enrollment":165},{"nctId":"NCT07111065","phase":"PHASE2","title":"FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2026-04-01","conditions":"Dermatomyositis (DM), Juvenile Dermatomyositis (JDM)","enrollment":300},{"nctId":"NCT03520101","phase":"NA","title":"Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2017-05-10","conditions":"Aortic Valve Stenosis, Regurgitation, Aortic, Prosthesis Failure","enrollment":102},{"nctId":"NCT06425510","phase":"NA","title":"Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas","status":"NOT_YET_RECRUITING","sponsor":"University of Puerto Rico","startDate":"2026-08-01","conditions":"Aging, Disability Physical","enrollment":76},{"nctId":"NCT07493356","phase":"","title":"Difficult Airway Prediction by Integrating STOP-BANG Criteria","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2026-03-09","conditions":"Ventilatory Defect, Intubation; Difficult or Failed","enrollment":233},{"nctId":"NCT07096388","phase":"","title":"Evaluation Of Cost-Effectiveness Of Iliac Branch Endoprostheses","status":"NOT_YET_RECRUITING","sponsor":"Prof. Andrea Kahlberg","startDate":"2026-05-01","conditions":"Aorto-iliac Aneurysm","enrollment":300},{"nctId":"NCT06368310","phase":"NA","title":"FIH Clinical Investigation of Graphene Electrodes for Brain Mapping","status":"RECRUITING","sponsor":"University of Manchester","startDate":"2024-08-06","conditions":"Brain Tumor, Glioma","enrollment":10},{"nctId":"NCT07492498","phase":"NA","title":"Telemedicine-Based Integrated Care for Heart Failure Prevention in Older Patients With Atrial Fibrillation (MIRACLE-AF III)","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Taizhou People's Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation, Heart Failure","enrollment":1268},{"nctId":"NCT07130357","phase":"NA","title":"The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-12-25","conditions":"Achilles Tendon Rupture","enrollment":48},{"nctId":"NCT03228641","phase":"NA","title":"Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity","status":"COMPLETED","sponsor":"Cytrellis Biosystems, Inc.","startDate":"2016-06-01","conditions":"Wrinkle, Facial and Neck Skin Laxity","enrollment":45},{"nctId":"NCT07492914","phase":"PHASE2","title":"Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-20","conditions":"Resected Head and Neck Cancer","enrollment":30},{"nctId":"NCT05699525","phase":"NA","title":"Personalized Mobile Cognitive Behavioral Therapy Application","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2024-08-02","conditions":"Anxiety Disorders and Symptoms, Depression, Bipolar Disorder","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7196,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Adriamycin"],"phase":"marketed","status":"active","brandName":"ADM","genericName":"ADM","companyName":"Italian Sarcoma Group","companyId":"italian-sarcoma-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ADM (doxorubicin) is an anthracycline chemotherapy agent that intercalates into DNA and inhibits topoisomerase II, leading to DNA damage and cell death. Used for Soft tissue sarcoma (as part of combination chemotherapy), Various solid tumors and hematologic malignancies.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}